Endothelin receptor - A blockade decreases ventricular arrhythmias after myocardial infarction in rats

被引:41
作者
Baltogiannis, GG
Tsalikakis, DG
Mitsi, AC
Hatzistergos, KE
Elaiopoulos, D
Fotiadis, DI
Kyriakides, ZS
Kolettis, TM
机构
[1] Univ Ioannina, Dept Cardiol, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Dept Comp Sci, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Dept Pathol, GR-45110 Ioannina, Greece
[4] Hellen Red Cross Hosp, Dept Cardiol, Athens 17123, Greece
关键词
arrhythmia (mechanisms); endothelins; infarction;
D O I
10.1016/j.cardiores.2005.04.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Endothelin-1 (ET-1) production increases during acute myocardial infarction (MI) and may contribute to the genesis of ventricular tachycardia, (VT) and ventricular fibrillation (VF). However, the antiarrhythmic effects of ET-I receptor blockade, examined shortly after MI, have been debated. In the present study, we examined the effects of such treatment on VT/VF during the first 24 h post-MI. Methods: Thirty-five Wistar rats (223 +/- 22 g) were randomly allocated to either the ET-I receptor-A (ETA) antagonist BQ-123 (0.4 mg/kg, BQ-123 group, n=17), or normal saline (control group, n=18) and were subjected to coronary artery ligation. A single-lead electrocardiogram was continuously recorded for 24 h post-MI, using an implanted telemetry system, and episodes of VT/VF were analyzed. Monophasic action potential (MAP) recordings were obtained from the left (LV) and right (RV) ventricular epicardium at baseline, 5 min after treatment and 24 h post-MI. Results: There were 15.94 +/- 19.35 episodes/h/rat of VT/VF in the control group and 1.66 +/- 2.22 in the BQ-123 group (p=0.010), resulting in a lower (p=0.030) arrhythmic mortality in treated animals. The mean episode duration was 7.40 +/- 7.16 s for the control group and 2.30 +/- 1.37 s for the BQ-123 group (p=0.011). The maximum decrease in VT/VF was observed during the 1st, 5th and 6th hours post-MI. In the control group, LV MAP duration increased 24 It post-MI, displaying an increased beat-to-beat variation, but remained unchanged in the BQ-123 group. Conclusion: Acute ETA blockade reduces the incidence of VT/VF during the first 24-h post-MI in the rat, through a decrease in the dispersion of repolarization. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:647 / 654
页数:8
相关论文
共 39 条
[1]   Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion [J].
Aguilar, AMA ;
Revert, F ;
Moya, A ;
Beltrán, J ;
García, J ;
San Martín, E ;
Sancho, S ;
Such, L .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 35 (03) :143-147
[2]   Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction [J].
Clozel, M ;
Qiu, CB ;
Qiu, CS ;
Hess, P ;
Clozel, JP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (01) :142-147
[3]   Anti-arrhythmic and electrophysiological effects of the endothelin receptor antagonists, BQ-123 and PD161721 [J].
Crockett, TR ;
Scott, GA ;
McGowan, NWA ;
Kane, KA ;
Wainwright, CL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 432 (01) :71-77
[5]   How to correct the QT interval for the effects of heart rate in clinical studies [J].
Davey, P .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2002, 48 (01) :3-9
[6]   EFFECT OF ACUTE CORONARY-ARTERY OCCLUSION ON SUB-EPICARDIAL TRANSMEMBRANE POTENTIALS IN INTACT PORCINE HEART [J].
DOWNAR, E ;
JANSE, MJ ;
DURRER, D .
CIRCULATION, 1977, 56 (02) :217-224
[7]   Endothelin and cardiac arrhythmias:: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? [J].
Duru, F ;
Barton, M ;
Lüscher, TF ;
Candinas, R .
CARDIOVASCULAR RESEARCH, 2001, 49 (02) :272-280
[8]   Current status of monophasic action potential recording: theories, measurements and interpretations [J].
Franz, MR .
CARDIOVASCULAR RESEARCH, 1999, 41 (01) :25-40
[9]   EFFECTS OF ENDOTHELIN-1 AND THE ET(A)-RECEPTOR ANTAGONIST, BQ123, ON ISCHEMIC ARRHYTHMIAS IN ANESTHETIZED RATS [J].
GARJANI, A ;
WAINWRIGHT, CL ;
ZEITLIN, IJ ;
WILSON, C ;
SLEE, SJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (04) :634-642
[10]   Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion [J].
Gourine, AV ;
Gonon, AT ;
Pernow, J .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (03) :H1105-H1112